https://www.pharmanow.live/latest-news/dermata-therapeutics-positive-topline-tome-foundational-treatment-cosmetic-study 2026-10-15T23:14:26+05:30 Pharma Now en 2026-10-15T00:00:00+05:30 Dermata Therapeutics Reports Positive Topline Data from Tome Foundational Treatment Cosmetic Study Dermata https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/8a0fc5c2-5b63-4de6-a666-f9b117c0d390/95698934-e644-43d5-a761-9bbd198af2f9.png https://www.pharmanow.live/latest-news/oryzon-secures-vafidemstat-patent-grants-four-markets-phase-iii-bpd 2026-10-15T23:13:49+05:30 Pharma Now en 2026-10-15T00:00:00+05:30 Oryzon Secures Vafidemstat Patent Grants in Four Markets Ahead of Phase III BPD Trial Oryzon Secures https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/8a0fc5c2-5b63-4de6-a666-f9b117c0d390/625ab622-0fa9-4b15-b763-ff2a7e8f4fab.png https://www.pharmanow.live/latest-news/zealand-pharma-generate-biomedicines-ai-obesity-drug-discovery-deal 2026-10-15T23:05:05+05:30 Pharma Now en 2026-10-15T00:00:00+05:30 Zealand Pharma Signs AI Drug Discovery Deal with Generate Biomedicines for Obesity Pipeline Zealand Pharma https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/8a0fc5c2-5b63-4de6-a666-f9b117c0d390/321b74c5-882d-4830-ac7c-fb39bcfe8239.png https://www.pharmanow.live/latest-news/rasonque-chmp-positive-opinion-metastatic-pancreatic-cancer-phased-review 2026-10-15T23:06:24+05:30 Pharma Now en 2026-10-15T00:00:00+05:30 Rasonque Gains CHMP Positive Opinion for Metastatic Pancreatic Cancer Rasonque CHMP https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/8a0fc5c2-5b63-4de6-a666-f9b117c0d390/050763b5-7f3a-4d34-8f70-25d5f894ce3a.png https://www.pharmanow.live/latest-news/lonza-completes-cdmo-transformation-divests-capsules-health-ingredients 2026-10-15T23:12:36+05:30 Pharma Now en 2026-10-15T00:00:00+05:30 Lonza Completes CDMO Transformation After Divesting Capsules and Health Ingredients Business Lonza https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/8a0fc5c2-5b63-4de6-a666-f9b117c0d390/9351d2ba-0c04-4605-a215-cb4a5388165d.png https://www.pharmanow.live/latest-news/evotec-appoints-dr-joanna-holbrook-chief-scientific-officer-november-2026 2026-10-15T23:11:23+05:30 Pharma Now en 2026-10-15T00:00:00+05:30 Evotec Appoints Dr. Joanna Holbrook as Chief Scientific Officer Evotec Appoints https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/8a0fc5c2-5b63-4de6-a666-f9b117c0d390/4fe1284a-02ff-454d-a874-da5cab98d82c.png https://www.pharmanow.live/latest-news/enodia-therapeutics-pfizer-500-million-deal-novel-drug-development 2026-10-15T23:04:18+05:30 Pharma Now en 2026-10-15T00:00:00+05:30 Enodia Therapeutics Signs $500 Million Deal with Pfizer for Novel Drug Development Enodia Therapeutics https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/8a0fc5c2-5b63-4de6-a666-f9b117c0d390/e5d7581e-6469-4dd3-8b95-fcdbeec487e9.png https://www.pharmanow.live/latest-news/insmed-palm-phase-3-tpip-dry-powder-inhaler-pulmonary-diseases 2026-10-15T23:03:25+05:30 Pharma Now en 2026-10-15T00:00:00+05:30 Insmed Advances Four Parallel Phase 3 Studies for TPIP Dry Powder Inhaler Insmed https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/8a0fc5c2-5b63-4de6-a666-f9b117c0d390/79c1d843-45a5-4715-a56d-dc2d904cfba9.png https://www.pharmanow.live/latest-news/par-health-recalls-22-lots-argatroban-injection-particulate-matter 2026-10-15T13:22:16+05:30 Pharma Now en 2026-10-14T00:00:00+05:30 Par Health Recalls 22 Lots of Argatroban Injection Par Health https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/par-health-argatroban-injection-recall-particulate-contamination-202620261015130629.webp https://www.pharmanow.live/latest-news/fda-cber-finalizes-blood-donation-suitability-source-plasma-quarantine-hold-compliance-policy 2026-10-15T12:59:03+05:30 Pharma Now en 2026-10-14T00:00:00+05:30 FDA Updates Blood Donation Compliance Policy FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-cber-blood-donation-compliance-policy-sop-reporting-202620261015125630.webp https://www.pharmanow.live/latest-news/fda-rare-disease-framework-initiative-risk-based-cmc-review-pre-approval-inspection 2026-10-15T12:52:39+05:30 Pharma Now en 2026-10-14T00:00:00+05:30 FDA Launches Rare Disease Framework Initiative FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-rare-disease-framework-risk-based-cmc-review-202620261015125229.webp https://www.pharmanow.live/latest-news/hepion-pharmaceuticals-acquires-gravitas-life-sciences-gv104-manufacturing 2026-10-15T12:49:03+05:30 Pharma Now en 2026-10-14T00:00:00+05:30 Hepion Pharmaceuticals Acquires Gravitas Life Sciences Hepion https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/hepion-pharmaceuticals-gravitas-life-sciences-acquisition-gv104-202620261015124859.webp https://www.pharmanow.live/latest-news/fibrobiologics-australian-patent-acceptance-fibroblast-spinal-disc-regeneration 2026-10-15T12:43:10+05:30 Pharma Now en 2026-10-14T00:00:00+05:30 FibroBiologics Secures Australian Patent for Disc Regeneration FibroBiologics https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fibrobiologics-australian-patent-spinal-disc-regeneration-202620261015124042.webp https://www.pharmanow.live/latest-news/fda-compliance-policy-blood-pressure-pulse-donor-eligibility-blood-establishments 2026-10-15T12:38:14+05:30 Pharma Now en 2026-10-14T00:00:00+05:30 FDA Issues Blood Pressure and Pulse Donor Eligibility Policy FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-blood-pressure-pulse-donor-eligibility-policy-202620261015123324.webp https://www.pharmanow.live/latest-news/atara-biotherapeutics-fda-accepts-tabelecleucel-bla-resubmission-march-2027-pdufa 2026-10-15T12:30:03+05:30 Pharma Now en 2026-10-14T00:00:00+05:30 FDA Accepts Atara Biotherapeutics’ Tabelecleucel BLA Atara https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/atara-biotherapeutics-tabelecleucel-fda-bla-resubmission-202620261015122827.webp https://www.pharmanow.live/latest-news/immunitybio-fda-expanded-approval-anktiva-high-grade-papillary-nmibc 2026-10-15T12:25:41+05:30 Pharma Now en 2026-10-14T00:00:00+05:30 FDA Expands ImmunityBio's Anktiva Approval FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/immunitybio-fda-expanded-anktiva-approval-papillary-bladder-cancer-202620261015122532.webp https://www.pharmanow.live/latest-news/roche-rona-therapeutics-1-16-billion-obesity-deal 2026-10-15T12:20:08+05:30 Pharma Now en 2026-10-14T00:00:00+05:30 Roche Strikes Up to $1.16B Obesity Deal With Rona Roche https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/roche-rona-therapeutics-1-16-billion-obesity-drug-deal-202620261015121820.webp https://www.pharmanow.live/latest-news/sanner-group-coo-frank-bamberg 2026-10-14T12:04:01+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Sanner Group COO Frank Bamberg Appointed to Lead Operations Sanner Group COO https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/sanner-group-coo-frank-bamberg20261014120301.webp https://www.pharmanow.live/latest-news/cervavac-who-prequalification-serum-institute 2026-10-14T11:50:48+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 CERVAVAC WHO Prequalification Secured by Serum Institute CERVAVAC WHO prequalification https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/cervavac-who-prequalification-hpv-vaccine20261014115040.webp https://www.pharmanow.live/latest-news/bix-2026-counts-down-to-opening-with-post-glp-1-session-on-the-next-obesity-treatment-market 2026-10-14T10:45:02+05:30 Pharma Now en 2026-10-14T00:00:00+05:30 BIX 2026 Counts Down to Opening with Post-GLP-1 Session on the Next Obesity Treatment Market BIX 2026, BIOPLUS INTERPHEX KOREA 2026, Post-GLP-1 obesity market, next-generation obesity treatments, BIX 2026 conference schedule https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/BIX2026Photo20261014104350.png https://www.pharmanow.live/latest-news/eurofins-sf-analytical-laboratories-fda-warning-letter-microbial-data-integrity-2026 2026-10-14T11:37:15+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Eurofins SF Analytical Laboratories FDA Warning Letter Issued Eurofins SF Analytical Laboratories FDA warning letter https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/eurofins-sf-analytical-laboratories-fda-warning-letter20261014113516.webp https://www.pharmanow.live/latest-news/lovelace-biomedical-fda-warning-letter-glp-raw-data-reconciliation-2026 2026-10-14T11:31:03+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Lovelace Biomedical FDA Warning Letter Cites GLP Data Failures Lovelace Biomedical FDA warning letter https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/lovelace-biomedical-fda-warning-letter20261014112901.webp https://www.pharmanow.live/latest-news/hanlim-pharm-fda-warning-letter-aseptic-failures-sterile-fill-finish-2026 2026-10-14T11:24:50+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Hanlim Pharm FDA Warning Letter Cites Aseptic Failures Hanlim Pharm FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/hanlim-pharm-fda-warning-letter20261014112229.webp https://www.pharmanow.live/latest-news/sca-pharmaceuticals-fda-warning-letter-503b-sterile-compounding-cgmp-2026 2026-10-14T11:17:28+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 SCA Pharmaceuticals Receives FDA Warning Letter Over CGMP Gaps SCA Pharmaceuticals receives FDA warning letter https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/sca-pharmaceuticals-fda-warning-letter-503b-cgmp-failures-202620261014111724.webp https://www.pharmanow.live/latest-news/bristol-myers-squibb-ryz101-phase-3-primary-endpoint-neuroendocrine-cancer 2026-10-14T11:04:24+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Bristol Myers Squibb’s RYZ101 Meets Phase 3 Endpoint in GEP-NETs Bristol Myers Squibb’s RYZ101, BMS RYZ101 https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/bms-ryz101-phase-3-endpoint-neuroendocrine-cancer-202620261014110417.webp https://www.pharmanow.live/latest-news/phio-pharmaceuticals-completes-first-commercial-scale-cgmp-batch-ph-762 2026-10-14T11:00:01+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Phio Pharmaceuticals Completes PH-762 Commercial-Scale Batch Phio Pharmaceuticals https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/phio-pharmaceuticals-commercial-scale-cgmp-batch-ph-762-202620261014105843.webp https://www.pharmanow.live/latest-news/lonza-qurient-exclusive-deal-dual-payload-adc-cancer-therapies 2026-10-14T10:55:18+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Lonza-Qurient Deal Expands Dual-Payload ADC Technology Lonza-Qurient https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/lonza-qurient-dual-payload-adc-cancer-therapies-202620261014105508.webp https://www.pharmanow.live/latest-news/perceptive-discovery-nucleus-radiopharma-partnership-radiopharmaceutical-development 2026-10-14T10:48:56+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Perceptive Discovery Partners With Nucleus RadioPharma Perceptive Discovery https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/perceptive-discovery-nucleus-radiopharma-partnership-radiopharmaceutical-development-202620261014104606.webp https://www.pharmanow.live/latest-news/zydus-formycon-fda-accepts-first-pembrolizumab-biosimilar-bla-review 2026-10-14T10:40:49+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Zydus & Formycon Secure FDA Review for Pembrolizumab Biosimilar Zydus & Formycon https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/zydus-formycon-fda-accepts-first-pembrolizumab-biosimilar-bla-review-202620261014103722.webp